A phase I/II escalation trial design T-RAD : Treatment of metastatic lung cancer with mRNA-engineered T cells expressing a T cell receptor targeting human telomerase reverse transcriptase (hTERT)
- Publication date
- 10 November 2022
- Publisher
- 'Frontiers Media SA'